Reckitt Benckiser is a producer of health, hygiene and home products. One of the fastest growing companies driving consumer health forward through innovation.
Who we are
We’re 37,000 entrepreneurs, all inspired by a vision of a world where people are healthier and live better. At the heart of our rapidly growing consumer health business is a passionate desire to help people feel better. We invest in research and development to find new ways for people to look after themselves, their families and homes.
Why we’re here
We believe there’s a better way to do business – we like to call it ‘betterbusiness’. Socially, environmentally and financially, we act responsibly and sustainably. We believe passionately in doing things the right way, and we believe the better way helps us deliver high quality products that touch consumers each and every day. Health is no longer just the absence of illness, it’s being able to lead a fitter and happier life. Our responsibility is to help people achieve this, while making the right kind of social and environmental impact. That’s what we call betterbusiness.
How we help
Life is changing, getting faster and more demanding. We provide solutions that help people deal with these new challenges. This is why we’re one of the fastest growing companies in one of the fastest growing markets – we drive consumer health forward through innovation.
In fact, we’ve redefined the consumer health market by combining our in-depth consumer knowledge with the speed of decision making we’ve gained in FMCG. Our culture of entrepreneurship puts ideas ahead of hierarchy, so we get the best ideas developed rapidly. This is why our brands are market leaders in most categories.
Contact
Reckitt Benckiser (Czech Republic), spol. s r.o.
Vinohradská 2828/151, 13000, Praha, Žižkov
phone : +420 227 110 111
email : cz@rb.com
website www.rb.com
The latest pharma news from Central and Eastern Europe (CEE), including a new report on the disparities between the region’s healthcare systems and those of Western Europe; why US companies…
Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country and beyond by positioning…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Czech Republic is available for download now. Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s…
Key stakeholders within the Czech medtech industry highlight how medical devices can improve efficiency and quality of care across the country’s healthcare landscape, why greater levels of collaboration are of…
Roman Samiec, general manager of Thuasne Czech Republic, introduces the company as a key competitor in the medical devices field, with their niche products addressing the unmet medical need in…
Miroslav Palát, president of CzechMed, the medical device association in the Czech Republic, and Jiří Pavlíček, who combines the responsibility of Chairman of the association and CEO of the medtech…
Pavla Nevolová, country head of EastHORN in the Czech Republic, shares the historical roots of the now multinational Czech CRO. Nevolová also shares her insights into the recent evolution of…
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of Central and Eastern Europe’s top destinations for clinical…
In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a billion Czech crowns to take over a state-owned producer of vitamins for which he had started working…
As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum, including prescription drugs, generics, over-the-counter (OTC) treatments, and food supplements, the…
Roman Dusil, GM of Pierre Fabre Laboratories in the Czech Republic and Slovakia, shares how the Czech affiliate is ahead of Pierre Fabre’s global transformation of the convergence between the dermo-cosmetic…
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or innovative therapies facing significant delays before…
See our Cookie Privacy Policy Here
